FLUID PHARMA LTD
Company number 10040765 · Active · Hatfield AL10 9NE
FLUID PHARMA LTD is an active private limited company (company number 10040765) incorporated on 3 March 2016, registered in Hatfield. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £46k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 23% on the prior period (£60k).
By net assets it sits in the upper half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Key dates
- Incorporated
- 3 March 2016
- Next accounts due
- 31 December 2026 — in 73 days
- Confirmation statement due
- 17 March 2027 — in 149 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 March 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £46k | — | — | — | — | — | 1 |
| 31 March 2024 | £60k | — | — | — | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 68/100 (grade B)
- +10 Positive net assets — Net assets £46,147 at 2025-03-31
- +8 Established — Incorporated 2016-03-03 (11 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Uh Holdings Limited (corporate entity) — owns 50–75% of shares; holds 50–75% of voting rights · since 30 September 2024
- Dr Fang Liu — owns 25–50% of shares; holds 25–50% of voting rights · since 30 September 2024
- Ip2ipo Limited (corporate entity) — owns 50–75% of shares · since 19 May 2016 · ceased 13 June 2017
- Ip2ipo Portfolio (Gp) Limited (corporate entity) — owns 50–75% of shares · since 13 June 2017 · ceased 30 September 2024
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Hertfordshire
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- TARGET TO TREATMENT (TTT) CONSULTING LIMITED — Stevenage, inc. Feb 2016
- SPOONER BIOANALYTICAL SOLUTIONS LTD — Hertford, inc. Dec 2015
- ROB DAVIS LIMITED — St. Albans, inc. Nov 2016
- MSC 2017 UK LTD — Welwyn Garden City, inc. Feb 2017
- SPUR THERAPEUTICS LIMITED — Stevenage, inc. Mar 2015
- VARANOU JENKINS SCIENTIFIC LTD — Henlow, inc. Mar 2017
Reminders for FLUID PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.